Liquidia (LQDA) Non Operating Income (2020 - 2026)
Liquidia (LQDA) posted quarterly Non Operating Income of -$4.7 million for Q1 2026, down 60.5% year-over-year from -$12.0 million in Q1 2025, and up 9.75% quarter-over-quarter from -$5.2 million in Q4 2025.
Liquidia (LQDA) Non Operating Income (2020 - 2026) Analysis & Trends
Liquidia's Non Operating Income history runs 7 years deep, the most recent figure standing at -$4.7 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 60.5% year-over-year to -$4.7 million; the TTM figure through Mar 2026 stood at -$19.3 million (down 123.26% YoY), while the FY2025 annual figure was -$17.5 million, down 150.79% from the prior year.
- Non Operating Income for Q1 2026 stood at -$4.7 million, up from -$5.2 million in the prior quarter.
- The five-year high for Non Operating Income was -$36000.0 in Q4 2022, with the low at -$5.3 million in Q3 2025.
- The 5-year median for Non Operating Income is -$1.5 million (2022), against an average of -$2.2 million.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income surged 82.09% in 2022, then tumbled 2716.67% in 2023.
- Liquidia's Non Operating Income stood at -$36000.0 in 2022, then sank by 2716.67% to -$1.0 million in 2023, then tumbled by 136.98% to -$2.4 million in 2024, then slumped by 117.73% to -$5.2 million in 2025, then grew by 9.75% to -$4.7 million in 2026.
- Business Quant data shows LQDA's Non Operating Income at -$4.7 million in Q1 2026, -$5.2 million in Q4 2025, and -$5.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Liquidia | 6.52 Bn | 6.23 Bn | 160.92 Mn | -3.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.82 Mn |
| Mar 31, 2026 | -4.72 Mn |
| Dec 31, 2025 | -5.23 Mn |
| Sep 30, 2025 | -5.30 Mn |
| Jun 30, 2025 | -4.07 Mn |
| Mar 31, 2025 | -2.94 Mn |
| Dec 31, 2024 | -2.40 Mn |
| Sep 30, 2024 | -1.84 Mn |
| Jun 30, 2024 | -1.47 Mn |
| Mar 31, 2024 | -1.28 Mn |
| Dec 31, 2023 | -1.01 Mn |
| Sep 30, 2023 | -899,000.00 |
| Jun 30, 2023 | -692,000.00 |
| Mar 31, 2023 | -2.51 Mn |
| Dec 31, 2022 | -36,000.00 |
| Sep 30, 2022 | -261,000.00 |
| Jun 30, 2022 | -477,000.00 |
| Mar 31, 2022 | -1.47 Mn |
| Dec 31, 2021 | -201,000.00 |
| Sep 30, 2021 | -201,000.00 |